Jian‐Ping Che

1.5k total citations
51 papers, 1.3k citations indexed

About

Jian‐Ping Che is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jian‐Ping Che has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Jian‐Ping Che's work include Renal cell carcinoma treatment (9 papers), Cancer-related gene regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jian‐Ping Che is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Cancer-related gene regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Jian‐Ping Che collaborates with scholars based in China and United States. Jian‐Ping Che's co-authors include Feng‐Qiang Yang, Haimin Zhang, Junhua Zheng, Min Liu, Guangchun Wang, Junhua Zheng, Yunfei Xu, Wei Li, Chen Shao-jun and Junhua Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and BioMed Research International.

In The Last Decade

Jian‐Ping Che

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Ping Che China 20 810 602 275 124 88 51 1.3k
Junhua Zheng China 22 638 0.8× 327 0.5× 285 1.0× 115 0.9× 192 2.2× 70 1.3k
Cheng Hu China 21 584 0.7× 321 0.5× 297 1.1× 109 0.9× 134 1.5× 71 1.1k
Sensuke Konno United States 17 338 0.4× 82 0.1× 154 0.6× 53 0.4× 76 0.9× 71 781
Thomas U. Ahearn United States 18 292 0.4× 354 0.6× 389 1.4× 85 0.7× 255 2.9× 43 1.1k
Shinichi Ikemoto Japan 14 401 0.5× 111 0.2× 144 0.5× 176 1.4× 241 2.7× 48 902
Ruimin Sun China 15 790 1.0× 498 0.8× 520 1.9× 93 0.8× 87 1.0× 33 1.3k
Lei Dong China 15 812 1.0× 453 0.8× 134 0.5× 70 0.6× 158 1.8× 34 1.3k
Ruizhi Tan China 21 716 0.9× 179 0.3× 149 0.5× 132 1.1× 89 1.0× 73 1.4k

Countries citing papers authored by Jian‐Ping Che

Since Specialization
Citations

This map shows the geographic impact of Jian‐Ping Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Ping Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Ping Che more than expected).

Fields of papers citing papers by Jian‐Ping Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Ping Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Ping Che. The network helps show where Jian‐Ping Che may publish in the future.

Co-authorship network of co-authors of Jian‐Ping Che

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Ping Che. A scholar is included among the top collaborators of Jian‐Ping Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Ping Che. Jian‐Ping Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Wentao, Zongtai Zheng, Keyi Wang, et al.. (2023). piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination. Experimental & Molecular Medicine. 55(6). 1258–1271. 27 indexed citations
3.
Li, Wei, Yineng Han, Xue Li, et al.. (2022). Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer. Theranostics. 12(3). 999–1011. 18 indexed citations
4.
Liu, Xiang, Liang Jin, Shiyong Xin, et al.. (2022). A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 13. 905518–905518. 15 indexed citations
5.
Che, Jian‐Ping, Pengfei Wu, Guangchun Wang, et al.. (2020). Expression and clinical value of SALL4 in renal cell carcinomas. Molecular Medicine Reports. 22(2). 819–827. 6 indexed citations
6.
Liao, Yun, Guanghui Hu, Yunfei Xu, et al.. (2017). Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae. Experimental and Therapeutic Medicine. 13(3). 1003–1010. 17 indexed citations
7.
Yang, Feng‐Qiang, Haimin Zhang, Jun Li, et al.. (2014). Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.. PubMed. 7(7). 4231–8. 14 indexed citations
8.
Yang, Yan, Feng‐Qiang Yang, Haimin Zhang, Jian‐Ping Che, & Junhua Zheng. (2014). Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumor Biology. 35(10). 10479–10486. 23 indexed citations
9.
Zhu, Wei, Yunfei Xu, Yuan Feng, et al.. (2014). Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model. Urolithiasis. 42(6). 519–526. 39 indexed citations
10.
Zhang, Haimin, Feng‐Qiang Yang, Chen Shao-jun, Jian‐Ping Che, & Junhua Zheng. (2014). Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biology. 36(4). 2947–2955. 191 indexed citations
11.
Yang, Yan, Yuan Feng, Wei Li, et al.. (2014). Protective effects of quercetin and hyperoside on renal fibrosis in rats with unilateral ureteral obstruction. Experimental and Therapeutic Medicine. 8(3). 727–730. 30 indexed citations
12.
Yang, Feng‐Qiang, Min Liu, Fengping Yang, et al.. (2014). VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α. Molecular Biology Reports. 41(3). 1511–1518. 23 indexed citations
13.
Liu, Min, Yongzhen Liu, Wei Li, et al.. (2013). Preventive effect of phosphodiesterase 5 inhibitor Tadalafil on experimental post-pyelonephritic renal injury in rats. Journal of Surgical Research. 186(1). 253–261. 10 indexed citations
14.
Li, Wei, Min Liu, Yunfei Xu, et al.. (2013). Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncology Reports. 31(1). 117–124. 102 indexed citations
15.
Geng, Jiang, Xiao‐Peng Zhang, Bo Peng, et al.. (2013). Statin use and risk of bladder cancer: a meta-analysis. Cancer Causes & Control. 24(4). 769–776. 35 indexed citations
16.
Wang, Guangchun, Junhua Zheng, Bin Yang, et al.. (2013). Impacts of Histological Prostatitis on Sexual Function and Lower Urinary Tract Symptoms in Patients With Benign Prostatic Hyperplasia. Urology. 82(5). 1094–1097. 7 indexed citations
17.
Liu, Min, Yongzhen Liu, Yuan Feng, et al.. (2012). Novel evidence demonstrates that epithelial-mesenchymal transition contributes to nephrolithiasis-induced renal fibrosis. Journal of Surgical Research. 182(1). 146–152. 13 indexed citations
18.
Xu, Yunfei, Min Liu, Bo Peng, et al.. (2011). Protective Effects of SP600125 on Renal Ischemia-Reperfusion Injury in Rats. Journal of Surgical Research. 169(1). e77–e84. 17 indexed citations
19.
Che, Jian‐Ping. (2009). The survival and prognosis of three common treatments for prostate carcinoma and the factors impacting on them. Zhongguo aizheng zazhi. 2 indexed citations
20.
Liu, Yushan, et al.. (2009). Retroperitoneal Laparoscopic Ureteroureterostomy for Retrocaval Ureter: Report of 7 Cases. Urology. 74(6). 1242–1245. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junhua Zheng Breakdown of academic impact, for papers by Cheng Hu Breakdown of academic impact, for papers by Sensuke Konno Breakdown of academic impact, for papers by Thomas U. Ahearn Breakdown of academic impact, for papers by Shinichi Ikemoto Breakdown of academic impact, for papers by Ruimin Sun Breakdown of academic impact, for papers by Lei Dong Breakdown of academic impact, for papers by Ruizhi Tan
Rankless by CCL
2026